Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA to weigh easing limits on unproven peptides promoted by RFK Jr.